HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xianjin Du Selected Research

Explosive Agents (Explosives)

1/2023Emergency Treatment and Photoacoustic Assessment of Spinal Cord Injury Using Reversible Dual-Signal Transform-Based Selenium Antioxidant.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xianjin Du Research Topics

Disease

6Inflammation (Inflammations)
10/2022 - 01/2016
4Sepsis (Septicemia)
10/2022 - 01/2020
3Neoplasms (Cancer)
01/2021 - 01/2018
3Atherosclerosis
12/2020 - 01/2019
2Pneumonia (Pneumonitis)
01/2020 - 01/2016
2Staphylococcal Pneumonia
01/2020 - 01/2016
1Wounds and Injuries (Trauma)
01/2023
1Spinal Cord Injuries (Spinal Cord Injury)
01/2023
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2021
1Reperfusion Injury
01/2021
1Infections
01/2021
1Neoplasm Metastasis (Metastasis)
12/2020
1Cardiovascular Diseases (Cardiovascular Disease)
01/2019
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
01/2018
1Renal Cell Carcinoma (Grawitz Tumor)
01/2018
1Ischemia
06/2014
1Myocardial Ischemia (Ischemic Heart Diseases)
06/2014
1Infarction (Infarctions)
06/2014
1Fibrosis (Cirrhosis)
06/2010
1Ureteral Obstruction
06/2010

Drug/Important Bio-Agent (IBA)

5Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
01/2020 - 01/2016
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 06/2014
3Interleukin-6 (Interleukin 6)IBA
01/2020 - 06/2014
3Proteins (Proteins, Gene)FDA Link
01/2018 - 06/2014
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023 - 01/2018
2Biomarkers (Surrogate Marker)IBA
10/2022 - 01/2019
2Apolipoproteins E (ApoE)IBA
12/2020 - 01/2019
2CytokinesIBA
01/2020 - 01/2016
2MicroRNAs (MicroRNA)IBA
01/2020 - 01/2020
1SeleniumIBA
01/2023
1Explosive Agents (Explosives)IBA
01/2023
1AntioxidantsIBA
01/2023
1LipopolysaccharidesIBA
10/2022
1dicarboxydine (DCD)IBA
01/2021
1Interleukin-1 (Interleukin 1)IBA
12/2020
1Interleukin-12 (IL 12)IBA
12/2020
1Lactic Acid (Lactate)FDA LinkGeneric
01/2020
1oxidized low density lipoproteinIBA
01/2019
1IronIBA
01/2019
1Long Noncoding RNAIBA
01/2019
1C-Type Lectins (C-Type Lectin)IBA
01/2018
1ErbB Receptors (EGF Receptor)IBA
01/2018
1NF-kappa B (NF-kB)IBA
01/2018
1Interleukin-1beta (Interleukin 1 beta)IBA
01/2018
1p38 Mitogen-Activated Protein KinasesIBA
01/2018
1Messenger RNA (mRNA)IBA
01/2016
1salicylhydroxamic acid (SHAM)IBA
01/2016
1Caspase 3 (Caspase-3)IBA
01/2016
1Surface-Active Agents (Surfactants)IBA
01/2016
1Creatine Kinase (Creatine Phosphokinase)IBA
06/2014
1HMGB1 Protein (HMG1)IBA
06/2014
1Exenatide (Byetta)FDA Link
06/2014
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
06/2014
1exendin (9-39)IBA
06/2014
1Glucagon-Like Peptide-1 ReceptorIBA
06/2014
1Connective Tissue Growth FactorIBA
06/2010
1Transforming Growth Factor beta (TGF-beta)IBA
06/2010

Therapy/Procedure

2Therapeutics
01/2021 - 01/2021
1Emergency Treatment
01/2023
1Ligation
10/2022
1Punctures
10/2022
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
10/2022
1Continuous Renal Replacement Therapy
01/2021
1Drug Therapy (Chemotherapy)
01/2021
1Immunotherapy
01/2021
1Extracorporeal Membrane Oxygenation
01/2021
1Radiotherapy
01/2021
1Artificial Respiration (Mechanical Ventilation)
01/2021
1Heterologous Transplantation (Xenotransplantation)
01/2018
1Subcutaneous Injections
01/2018